![]() |
市場調查報告書
商品編碼
2046187
一次性內視鏡市場-全球產業規模、佔有率、趨勢、機會、預測:按類型、最終用戶、地區和競爭格局分類,2021-2031年Disposable Endoscopes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By End User, By Region & Competition, 2021-2031F |
||||||
全球一次性內視鏡市場預計將從 2025 年的 35.1 億美元大幅成長至 2031 年的 55.2 億美元,複合年成長率為 7.84%。
這些無菌一次性醫療設備設計為在單次手術後立即丟棄,省去了傳統可重複使用器械所需的複雜再處理步驟。此市場成長的主要驅動力是降低醫院感染的迫切需求,特別是透過受污染的十二指腸鏡和支氣管鏡傳播的多重抗藥性感染。此外,醫療機構擴大採用這些器械,以避免清潔和消毒相關的運作人事費用、停機時間和化學品暴露風險,從而提高營運效率。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 35.1億美元 |
| 市場規模:2031年 | 55.2億美元 |
| 複合年成長率:2026-2031年 | 7.84% |
| 成長最快的細分市場 | 醫院 |
| 最大的市場 | 北美洲 |
然而,一次性內視鏡廣泛應用面臨的一大挑戰是其對環境造成的巨大影響。這些設備產生的大量醫療廢棄物引發了人們永續性的嚴重擔憂,醫療機構正在積極採取措施應對這些問題。例如,根據醫療醫療設備再加工商協會的一份報告,到2025年,透過醫療機構對一次性醫療器材進行再加工,可以避免超過1,200萬磅的廢棄物最終被掩埋。這凸顯了一次性內視鏡產業可能帶來的巨大環境負擔。
全球一次性內視鏡市場的主要驅動力是預防交叉感染和院內感染(HAI)的迫切需求。可重複使用的器械,特別是具有複雜升降機構的十二指腸內視鏡,在消毒方面面臨巨大挑戰,並經常被認為是導致多重抗藥性細菌傳播的因素之一。這個關鍵的安全問題正推動市場迅速轉向無菌的一次性內視鏡替代方案,從而從根本上消除患者間的病原體傳播途徑。例如,Ambu A/S 在其 2024/25 會計年度年度報告(2025 年 11 月)中指出,其內視鏡解決方案業務實現了 15.4% 的內部成長,這一成長直接歸功於為應對緊迫的感染控制要求而加速採用一次性解決方案。
同時,一次性內視鏡成像技術的快速發展使其影像品質可與傳統可重複使用平台相媲美,克服了以往推廣應用的障礙。高解析度數位感測器和人體工學設計的進步,使得這些一次性設備即使在更複雜的手術中也能發揮臨床應用價值,從而提高了其在各類醫療機構中被醫生接受度。隨著醫療機構尋求在性能和營運效率之間取得平衡,這種臨床效用的提升正在推動顯著的商業性成長。波士頓科學公司在2025年2月發布的《2024年第四季財務及業務亮點》中報告稱,其一次性成像業務實現了兩位數的成長,這反映了這些先進技術的廣泛應用。內視鏡產業是一個極其大規模的市場,光是波士頓科學公司的內視鏡部門累計在2025年就將實現26.87億美元的淨銷售額,凸顯了支撐這些創新一次性技術的市場實力。
全球一次性內視鏡市場進一步成長的主要障礙之一是其對環境造成的巨大影響。隨著全球醫療醫療設備競相實現雄心勃勃的碳中和目標,不可生物分解塑膠廢棄物的堆積與機構的永續性要求直接衝突。這種環境負擔迫使醫院管理者在權衡一次性內視鏡的感染控制優勢與醫療廢棄物增加可能帶來的聲譽損害和運營困難之間做出艱難抉擇,這往往導致採購部門推遲從可重複使用設備過渡到一次性內視鏡的進程。
如此龐大的碳足跡構成了推廣應用的一大障礙。這些設備的生產和處置都會顯著增加溫室氣體排放,這一點正受到監管機構日益嚴格的審查。例如,醫療設備再加工商協會報告稱,到2024年,該行業需要透過再加工工作減少超過2,300萬英鎊的二氧化碳排放,以減輕其影響。這項數據凸顯了一次性產品供應鏈中潛在的巨大碳排放負擔,隨著環境責任日益重要,這問題也持續阻礙市場成長前景。
市場關鍵趨勢之一是永續和可生物分解醫療設備材料的出現,這對於應對大量醫療廢棄物造成的環境問題至關重要。製造商正加速從根本上重新思考醫療設備的結構,超越基本的回收利用,並採用生物基聚合物來減少生產過程中對石化燃料的依賴。這項變革使醫療機構能夠在維持一次性器材無菌性和工作流程優勢的同時,主動減少碳足跡。這正日益成為醫院採購決策中的重要因素。正如Ambu A/S在其2024/25會計年度年度報告(2025年11月)中所述,該公司已成功將生質塑膠應用於目前市場上所有內視鏡的手柄中,為減少一次性醫療設備的環境影響樹立了新的行業標準。
同時,市場正經歷顯著的多元化發展,從傳統的胃腸領域擴展到泌尿系統和支氣管鏡檢查等專業領域。這一趨勢源自於可重複使用輸尿管鏡和支氣管鏡固有的複雜性和易損性。這些器械在再處理過程中容易損壞,並且始終存在交叉感染的風險。因此,醫療專業人員正在迅速採用高性能的一次性替代方案,以確保在這些複雜的手術中設備的穩定供應和病人安全。這種快速普及也反映在財務表現上。波士頓科學公司發布的2024年第四季財務及業務亮點報告(2025年2月發布)顯示,其一次性影像業務部門的有機銷售額實現了兩位數成長,凸顯了泌尿系統和膽道介入治療領域對專用一次性平台的需求正在加速成長。
The global disposable endoscopes market is projected to expand significantly, from USD 3.51 billion in 2025 to USD 5.52 billion by 2031, demonstrating a compound annual growth rate (CAGR) of 7.84%. These sterile, single-use medical devices are designed for immediate disposal after one procedure, thereby eliminating the intricate reprocessing steps necessary for conventional reusable instruments. This market's growth is primarily fueled by the critical necessity to reduce hospital-acquired infections, especially those caused by multidrug-resistant organisms transmitted via contaminated duodenoscopes and bronchoscopes. Furthermore, healthcare facilities are increasingly adopting these devices to improve operational efficiency, bypassing the labor expenses, downtime, and risks of chemical exposure associated with cleaning and sterilization.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 3.51 Billion |
| Market Size 2031 | USD 5.52 Billion |
| CAGR 2026-2031 | 7.84% |
| Fastest Growing Segment | Hospitals |
| Largest Market | North America |
However, a notable challenge to the widespread adoption of disposable endoscopes is the considerable environmental impact of single-use plastics. The substantial volume of medical waste generated by these devices raises significant sustainability concerns that institutions are actively working to address. For instance, in 2025, the reprocessing of single-use devices by healthcare facilities diverted over 12 million pounds of waste from landfills, as reported by the Association of Medical Device Reprocessors, underscoring the substantial ecological footprint that would otherwise result from the disposable endoscopy sector.
Market Driver
The primary force driving the global disposable endoscopes market is the urgent need to prevent cross-contamination and hospital-acquired infections (HAIs). Reusable devices, especially duodenoscopes with their intricate elevator mechanisms, pose considerable sterilization challenges and have frequently been implicated in transmitting multidrug-resistant organisms. This critical safety concern has prompted a swift shift towards sterile, single-use alternatives that inherently eliminate the pathway for pathogen transmission between patients. For instance, Ambu A/S reported in their 'Annual Report 2024/25' (November 2025) a 15.4% organic growth in their Endoscopy Solutions business, directly attributing this surge to the accelerated adoption of single-use modalities in response to pressing infection control mandates.
Concurrently, swift technological progress in single-use endoscopic imaging is overcoming past adoption hurdles by providing visualization quality comparable to traditional reusable platforms. Advances in high-definition digital sensors and ergonomic designs have made these disposable devices clinically viable for more complex procedures, consequently increasing their acceptance among physicians in various healthcare settings. This enhanced clinical utility is fueling significant commercial growth as providers seek to balance performance with operational efficiency. Boston Scientific, in their 'Q4 2024 Financial & Operational Highlights' (February 2025), noted double-digit growth in their single-use imaging franchises, reflecting the increasing use of these advanced technologies. The endoscopy sector operates on a substantial scale; Boston Scientific's Endoscopy segment alone generated net sales of $2,687 million in 2025, highlighting the strong market supporting these disposable innovations.
Market Challenge
A significant impediment to the wider growth of the global disposable endoscopes market is the substantial environmental impact linked to single-use medical devices. With healthcare systems worldwide pursuing ambitious carbon neutrality objectives, the buildup of non-biodegradable plastic waste directly conflicts with institutional sustainability requirements. This environmental burden compels hospital administrators to carefully balance the infection-control advantages of disposable scopes against the potential reputational damages and operational difficulties of handling increased medical waste, frequently leading procurement departments to delay transitioning from reusable equipment.
The considerable scale of this carbon footprint acts as a tangible barrier to adoption. The manufacturing and disposal of these devices contribute significantly to greenhouse gas emissions, an aspect under increasing scrutiny from regulatory authorities. For instance, the Association of Medical Device Reprocessors reported that in 2024, the sector needed to eliminate over 23 million pounds of CO2 emissions through reprocessing efforts to lessen this impact. This statistic highlights the immense potential carbon load inherent in the single-use supply chain, which continues to hinder the market's growth prospects during a period of heightened environmental responsibility.
Market Trends
A significant market trend involves the emergence of sustainable and biodegradable device materials, serving as a crucial response to the environmental issues stemming from high volumes of medical waste. Manufacturers are increasingly advancing beyond basic recycling efforts to fundamentally rethink device construction, incorporating bio-based polymers to lessen reliance on fossil fuels in production. This evolution enables healthcare facilities to retain the sterility and workflow advantages of single-use instruments while actively lowering their carbon footprint, a consideration that is increasingly pivotal in hospital purchasing decisions. As reported by Ambu A/S in their 'Annual Report 2024/25' (November 2025), the company has successfully integrated bioplastics into the handles of all its current endoscopes, setting a new industry standard for reducing the ecological impact of disposable medical devices.
Concurrently, the market is experiencing a notable diversification into specialized urology and bronchoscopy applications, extending beyond the conventional gastrointestinal segment. This trend is fueled by the inherent complexity and vulnerability of reusable ureteroscopes and bronchoscopes, which are susceptible to damage during reprocessing and pose ongoing risks of cross-contamination. Consequently, healthcare providers are quickly adopting high-performance disposable alternatives for these intricate procedures to ensure both consistent device availability and patient safety. This strong adoption is reflected in financial results; Boston Scientific's 'Q4 2024 Financial & Operational Highlights' (February 2025) indicated double-digit organic revenue growth in their single-use imaging franchises, highlighting the accelerating demand for specialized disposable platforms in urological and biliary interventions.
Report Scope
In this report, the Global Disposable Endoscopes Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Disposable Endoscopes Market.
Global Disposable Endoscopes Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: